Navigation Links
First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System
Date:5/15/2008

Excellent results obtained with a newly cleared device to identify the lipid core (fatty) coronary plaques of interest that are associated with

complications of coronary stenting

BURLINGTON, Mass., May 15 /PRNewswire/ -- InfraReDx, Inc. today announced that physicians at Beaumont Hospital in Royal Oak, Mich., have successfully used its LipiScan(TM) Coronary Imaging System in a patient undergoing a cardiac catheterization. This is the first patient in the world in whom it has been possible to assess the chemical composition of coronary artery plaques and utilize such information to assist in the management of coronary artery disease.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080515/NETH104 )

Dr. Daniel Schultz, Director of the FDA Center for Devices and Radiological Health, has stated, "This is the first device that can help assess the chemical make-up of coronary artery plaques and help physicians identify those plaques with lipid cores, which may be of particular concern."

Physicians at Beaumont Hospital performed the procedure on May 8, 2008 in a 70-year old male patient. The LipiScan System revealed the presence of a lipid core containing plaque not detectable by conventional diagnostic measures. This fatty plaque was located near a narrowing that required a coronary stent for the usual reasons. Because of the presence of this plaque, the physicians selected a stent that was 50 percent longer than the one that would have been used to cover the narrowing only. This longer stent covered the lipid core containing plaque and avoided placing the end of a shorter stent in the fatty plaque. Termination of a stent in a fatty plaque has been associated with clotting of the stent years after placement.

"If doctors can identify these fatty plaques, we can recommend better treatment options to patients," says Simon Dixon, M.D.
'/>"/>

SOURCE InfraReDx, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013  Modern Medical announced ... (ODM).  Launched in November 2012 in a test ... program to stop the rising opioid abuse in ... customized program designed to protect employees, physicians and ... the necessary balance to provide pain relief for ...
(Date:5/22/2013)... N.C. , May 22, 2013 STEPh, ... to announce the launch of their web site ( ... [STEPh Reports].  About STEPh Reports ... in development.  Each STEPh Report assesses ... trials data, projected launch year, company, and specific key ...
(Date:5/22/2013)... 2013 MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) would ... some recent company developments. As Medifirst continues to expand ... with shareholders. Integrating social media into its investor relations ... will post updates on Twitter.  The Facebook homepage is ... Says CEO Bruce J. Schoengood ...
Breaking Medicine Technology:Modern Medical Introduces Opioid Abuse Solution to the Workers' Compensation Industry 2Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2Medifirst Solutions, Inc. Announces Update To Shareholders 2
... of,Justice announced today that it will not oppose ... to develop and publicize model contract language,for clinical ... said,the language is not likely to be anticompetitive ... contract negotiations, potentially reducing costs,and shortening the time ...
... and TORONTO, Sept. 17 Sanofi pasteur, the,vaccines ... it is,sponsoring a Phase II clinical study exploring ... melanoma -- an often fatal form of,cancer for ... being,enrolled in the United States and Canada. The ...
Cached Medicine Technology:Justice Department Will Not Oppose CEO Roundtable on Cancer's Proposal 2Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 2Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 3Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 4Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 5
(Date:5/22/2013)... 2013 The new 13-valent pneumococcal conjugate vaccine (PCV13) ... used prior to 2010, the 7-valent pneumococcal conjugate vaccine ... in Vaccine . , The U.S. Food and ... after a series of trials. These trials found that ... types than the previously used PCV7, did not increase ...
(Date:5/22/2013)... NY (PRWEB) May 22, 2013 ... now have access to Adapt Courseware’s new ... in an adaptive framework that responds based on ... Courseware , the provider of comprehensive adaptive online ... is continuing to develop introductory level general education ...
(Date:5/22/2013)... New Jersey (PRWEB) May 22, 2013 ... incredible gift card system, fit for the busy lifestyle of ... is select a design appropriate for the occasion, whether it ... or an apology note, or any other occasion. , Clients ... New Jersey spa gift card designs on the Ethos ...
(Date:5/22/2013)... 22, 2013 TheBeautyPlace.com features Toppik and Bosley ... up any remnants of thinning or balding hair. Hair loss ... the appearance of hair loss during this waiting period, one ... used as an alternative to hair transplant surgery in general. ... safe and an extremely effective way to eliminate the appearance ...
(Date:5/22/2013)... The health care crisis in the United States is ... percent of all adults are without health insurance. Further, ... U.S. are related to medical bills. The high price ... patients cannot afford to take their prescriptions as directed by ... That's why MedicationDiscountCard.com is offering savings of up to seventy-five ...
Breaking Medicine News(10 mins):Health News:Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine 2Health News:Adapt Courseware Releases Introduction to Sociology for Colleges and Universities Nationwide 2Health News:Adapt Courseware Releases Introduction to Sociology for Colleges and Universities Nationwide 3Health News:Ethos Spa Skin And Laser Center Has Launched Their Customizable Gift Certificates 2Health News:TheBeautyPlace.com Divulges Two Innovative Hair Loss Concealers on the Market Today: Bosley Hair Thickening Fibers and Toppik Hair Building Fibers 2Health News:Lyrica Discount Cards Now Available From MedicationDiscountCard.com 2
... published in the November issue of the Springer journal ... absorptiometry has been cut to levels substantially below the ... physicians and clinics around the country are likely to ... access to the test and jeopardizing those at risk ...
... Employees,International Union (SEIU), the nation,s largest labor union for ... the diagnosis of,and prescription for mending our broken health ... On the heels of a historic election where voters ... health care costs as their number one,economic concern -- ...
... Regarding Protecting,Children from the Flu, ARLINGTON, Va., Nov. 12 , ... of Child Care Professionals (NACCP), Families ... Coalition (CIIC) are launching the second annual nationwide flu ... in Child Care Settings: Building Blocks ...
... Team by 30%, MENLO PARK, Calif., Nov. ... a leading venture capital firm celebrating,40 years of ... its,fundraising goal and closed its ninth fund at ... total capital under management to $2.6,billion. Morgenthaler Venture ...
... launched a totally new advanced skincare range that is designed ... just for ... millions of,concerned mums who have 12-24 year old boys suffering with spots ... totally new advanced skincare range that is designed,just for boys, helping to ...
... whites, 19% for blacks, 21% for Hispanics and 27% for ... -- Minority children waiting for a heart transplant have a ... eight years of data from the United Network of Organ ... 3,299 children waiting for a heart transplant. Of those, 58 ...
Cached Medicine News:Health News:Osteoporosis care at risk in the United States 2Health News:SEIU Statement in Support of New Blueprint to Solve Health Care Crisis by Senator Max Baucus 2Health News:Audio: NACCP, Families Fighting Flu, and the Childhood Influenza Immunization Coalition Team Up to Educate Families About Annual Childhood Flu Vaccination 2Health News:Audio: NACCP, Families Fighting Flu, and the Childhood Influenza Immunization Coalition Team Up to Educate Families About Annual Childhood Flu Vaccination 3Health News:Audio: NACCP, Families Fighting Flu, and the Childhood Influenza Immunization Coalition Team Up to Educate Families About Annual Childhood Flu Vaccination 4Health News:Morgenthaler Closes Ninth Fund at $400 Million 2Health News:Morgenthaler Closes Ninth Fund at $400 Million 3Health News:Morgenthaler Closes Ninth Fund at $400 Million 4Health News:OXY Launches Young Male Skincare Range - a UK First 2Health News:Death Rates Higher for Minority Children Awaiting Heart Transplant 2
Provides a combination of concentrated cold / hot and compression for any part of the body...
Provides a combination of concentrated cold / hot and compression for the knee...
Provides extended cold therapy for acute, chronic, or post-surgical applications. Cryotherapy can reduce pain, swelling and speed recovery....
Provides a combination of concentrated cold / hot and compression for the back...
Medicine Products: